AR010808A1 - Uso de un compuesto para la fabricacion de un medicamento util para tratar o inhibir neutropenia y/o para acelerar la recuperacion de neutrofilos y unacomposicion farmaceutica - Google Patents

Uso de un compuesto para la fabricacion de un medicamento util para tratar o inhibir neutropenia y/o para acelerar la recuperacion de neutrofilos y unacomposicion farmaceutica

Info

Publication number
AR010808A1
AR010808A1 ARP970105989A ARP970105989A AR010808A1 AR 010808 A1 AR010808 A1 AR 010808A1 AR P970105989 A ARP970105989 A AR P970105989A AR P970105989 A ARP970105989 A AR P970105989A AR 010808 A1 AR010808 A1 AR 010808A1
Authority
AR
Argentina
Prior art keywords
carbon atoms
alkyl
compound
hydrogen
neutrophils
Prior art date
Application number
ARP970105989A
Other languages
English (en)
Spanish (es)
Original Assignee
American Cyanamid Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Cyanamid Co filed Critical American Cyanamid Co
Publication of AR010808A1 publication Critical patent/AR010808A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A61K31/5377—1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ARP970105989A 1996-12-19 1997-12-18 Uso de un compuesto para la fabricacion de un medicamento util para tratar o inhibir neutropenia y/o para acelerar la recuperacion de neutrofilos y unacomposicion farmaceutica AR010808A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US77074396A 1996-12-19 1996-12-19

Publications (1)

Publication Number Publication Date
AR010808A1 true AR010808A1 (es) 2000-07-12

Family

ID=25089545

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP970105989A AR010808A1 (es) 1996-12-19 1997-12-18 Uso de un compuesto para la fabricacion de un medicamento util para tratar o inhibir neutropenia y/o para acelerar la recuperacion de neutrofilos y unacomposicion farmaceutica

Country Status (7)

Country Link
EP (1) EP0957918A1 (fr)
JP (1) JP2001506998A (fr)
AR (1) AR010808A1 (fr)
AU (1) AU5611398A (fr)
CA (1) CA2273288A1 (fr)
WO (1) WO1998026781A1 (fr)
ZA (1) ZA9711342B (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11116738B2 (en) 2012-06-07 2021-09-14 Children's Hospital Los Angeles Methods for treating neutropenia using retinoid agonists
US10286039B2 (en) 2014-02-18 2019-05-14 Children's Hospital Los Angeles Compositions and methods for treating neutropenia

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2615291B1 (fr) * 1987-05-15 1989-07-13 Thomson Csf Procede de test en fonctionnement d'un dispositif de visualisation d'informations radar et mise en oeuvre de ce procede
US4916137A (en) * 1988-02-22 1990-04-10 American Cyanamid Company 5-(Substituted-amino)-8-(phenyl or substituted-phenyl)-3H,6H-1,4,5A,8A-tetraazaacenaphthylen-3-ones and treatment of neural behavior disorders
ATE99686T1 (de) * 1988-02-22 1994-01-15 American Cyanamid Co 5-(substituierte amino)-8-(phenyl oder substituierte phenyl)-3h,6h-1,4,5a,8atetraazaacenaphthylen-3-one.

Also Published As

Publication number Publication date
CA2273288A1 (fr) 1998-06-25
AU5611398A (en) 1998-07-15
WO1998026781A1 (fr) 1998-06-25
JP2001506998A (ja) 2001-05-29
EP0957918A1 (fr) 1999-11-24
ZA9711342B (en) 1999-06-17

Similar Documents

Publication Publication Date Title
KR950010890A (ko) 폐경기 증후군의 치료방법
AR035482A1 (es) Uso de un compuesto de cianoquinolina para la manufactura de un medicamento para tratar o inhibir polipos colonicos
PE20010126A1 (es) Pirrolotriazinas como inhibidores de cinasas
KR910007525A (ko) 양모제
AR005706A1 (es) Inhibidores egfr de 4-aminoquinzolina, procedimiento para su obtencion, composicion farmaceutica que los contiene, uso de los mismos para lapreparacion de un medicamento util como agente antineoplasico
KR960014121A (ko) 아로일-피페리딘 유도체
KR890001537A (ko) 5ht-3 길항제의 용도
KR920004396A (ko) 42-옥소라파마이신
TR199901528T2 (xx) Viral enfeksiyonlar ve kanser tedavisinde benzimidazol-2-karbamatlar�n kullan�m�.
KR940701264A (ko) 안과질환에 대한 마크로라이드 화합물의 용도
KR950016745A (ko) 생리증상의 치료방법 및 이를 위한 조성물
AR053364A1 (es) Compuesto de 1h-imidazo 84,5-c) piridin -2- ilo, composicion farmaceutica que lo comprende, proceso para prepararla y su uso para preparar un medicamento para tratamiento de cancer o artritis
PE20010541A1 (es) Uso de una composicion de benzimidazol para tratar el cancer
KR970707108A (ko) 항염증제로 유용한, 복소환부를 갖는 디-t-부틸페놀 화합물(DI-TERT-BUTYLPHENOL COMPOUNDS WITH HETEROCYCLIC MOIETY, USEFUL AS ANTI-INFLAMMATORY AGENTS)
KR950010891A (ko) 내성 종양을 치료하는 방법
AR040274A1 (es) Derivados de 1-[(indol-3-il)carbonil]piperazina como agonistas de canabinoides en el tratamiento del dolor y composiciones farmaceuticas
KR960700696A (ko) 정맥성 질환 치료에 유용한 5-하이드록시트립타민-2 수용체 길항물질 조성물(5-ht₂receptor antagonist compositions useful in treating venous conditions)
AR010808A1 (es) Uso de un compuesto para la fabricacion de un medicamento util para tratar o inhibir neutropenia y/o para acelerar la recuperacion de neutrofilos y unacomposicion farmaceutica
KR930006024A (ko) 이미다조 인돌리진 유도체 및 그의 제조방법
KR890017252A (ko) 티에노트리아졸로디아제핀 화합물 및 그의 약학적 용도
KR890008063A (ko) 소염제로서 유용한 3급-부틸페닐 화합물
ATE286503T1 (de) (hetero)aryl-sulfonamid derivate, deren herstellung und deren verwenddung als faktor xa inhibitoren
FR2617476B1 (fr) Nouveaux derives polycycliques aromatiques, leur procede de preparation et leur utilisation en medecine humaine et veterinaire et en cosmetique
KR910011807A (ko) 4-벤질-5-페닐-2,4-디히드로-3h-1,2,4-트리아졸-3-온 및 진경제로서의 그 의 용도
KR880007498A (ko) 중추작용 근이완제